Allakos Inc.

About Allakos Inc.

Allakos Inc. is a clinical-stage biotechnology company focused on developing therapeutics targeting immunomodulatory receptors on immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company’s pipeline includes biologic drug candidates designed to address unmet medical needs in these areas. Allakos operates primarily in the biopharmaceutical sector, leveraging intellectual property and third-party manufacturing to advance clinical development and regulatory approval for specialty patient populations.